How to reach the target blood pressure level according to the 2018 European recommendations? Reserve possibilities of phytomolecules

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: Nov 30, 2018
DOI: https://doi.org/10.30841/2307-5112.5.2018.165370
Keywords:
arterial hypertension, comorbid conditions, combined tablet, phytomolecules, flavonoids,

##plugins.themes.bootstrap3.article.main##

М. М. Долженко
P.L. Shupyk National Medical Academy of Postgraduate Education, Ukraine
В. А. Несукай
P.L. Shupyk National Medical Academy of Postgraduate Education, Ukraine
С. А. Бондарчук
P.L. Shupyk National Medical Academy of Postgraduate Education, Ukraine
О. В. Шершнева
Zaporizhzhia State Medical University, Ukraine
І. В. Чорна
Zaporizhzhia State Medical University, Ukraine

Abstract

The article highlights the prevalence of arterial hypertension (AH). Attention is paid to the classification of hypertension and target blood pressure (BP). The classification of hypertension according to the level of blood pressure, the presence of cardiovascular risk factors, target organ damage and / or the presence of associated diseases helps to optimize individual treatment. Correction of treatment is also carried out depending on the initial level of blood pressure and comorbid pathology. Attention is focused on the need for the appointment in many cases, immediately combined antihypertensive therapy. Such drugs, in addition to many well-known tableted drugs, are also drugs of plant origin. On the example of the herbal preparation Neocardil, from the standpoint of evidence, the place of flavonoids in the treatment of patients with hypertension is considered.

##plugins.themes.bootstrap3.article.details##

How to Cite
Долженко, М. М., Несукай, В. А., Бондарчук, С. А., Шершнева, О. В., & Чорна, І. В. (2018). How to reach the target blood pressure level according to the 2018 European recommendations? Reserve possibilities of phytomolecules. Family Medicine, (5), 41–46. https://doi.org/10.30841/2307-5112.5.2018.165370
Issue
No. 5 (2018)
Section
Topical issues
Copyright (c) 2020 М. М. Долженко, В. А. Несукай, С. А. Бондарчук, О. В. Шершнева, І. В. Чорна

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

М. М. Долженко, P.L. Shupyk National Medical Academy of Postgraduate Education

Maryna M. Dolzhenko,

Head of Department of Cardiology

В. А. Несукай, P.L. Shupyk National Medical Academy of Postgraduate Education

Vitalii A. Nesukai,

Department of Cardiology

С. А. Бондарчук, P.L. Shupyk National Medical Academy of Postgraduate Education

Serhii A. Bondarchuk,

Department of Cardiology

О. В. Шершнева, Zaporizhzhia State Medical University

Oksana V. Shershneova,

Department of Family Medicine

І. В. Чорна, Zaporizhzhia State Medical University

Inna V. Chorna,

Department of Internal Diseases № 2

References

Европейское исследование профилактики сердечно-сосудистых заболеваний и сахарного диабета EUROASPIRE IV: результаты госпитального этапа в Украине. Коваленко В.Н., Долженко М.Н., Несукай Е.Г. от группы исследователей EUROASPIRE IV в Украине / УКЖ. – 2016. – № 4. PDF

Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension / Eur Heart J. 2018 Sep 1;39(33):3021–3104. https://doi.org/10.1093/eurheartj/ehy339

Эффективность применения препарата Неокардил для регуляции когнитивной дисфункции у больных с факторами риска сердечно-сосудистых заболеваний /М.М. Долженко, О.О. Нудченко, С.З. Лурье, Я.С. Дьяченко, К.С. Фарадж, К.А. Каминская, А.Я. Базилевич // Семейная медицина. – 2016. – № 2 (64). – C. 71–76.

Оцінювання ефективності застосування препарату Неокардил для зменшення факторів ризику розвитку захворювань серцево-судинної системи при первинній профілактиці / М.М. Долженко, О.О. Нудченко, С.З. Лур’є, Х.А. Камінська, А.Я. Базилевич, І.В. Філімонова // Семейная медицина. – 2014. – № 6. – С. 45–50.

Применение Неокардила в лечении вегето-сосудистой дистонии // М.Н. Долженко, А.И. Фролов, О.И. Гай // НОВОСТИ МЕДИЦИНЫ И ФАРМАЦИИ. – 2012. – № 8 (410). Full text

Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure // Cochrane datebase Syst Rew. – 2008. – Jan № 23 (1). https://doi.org/10.1002/14651858.CD005312.pub2

Hertog M.G.L., Feskens E.G.M., Kronhout D. Dietery antioxidants flavonoids and risk of cardiovascular disease: the Zutphen Elderly Study // The Lancet. – 1993. – V. 342. – Issue 8878. – P. 1008–1011. https://doi.org/10.1016/0140-6736(93)92876-U

Chen JD, Wu YZ, Tao ZL et al. Hawthorn (Shan Zha) drink and its lowering affect on blood lipids level in humans and rats. World Rev Nutr Diet. – 1995. – № 77. – P. 147–154. https://doi.org/10.1159/000424470

Zapato J.M. Selections from current literature: effects of Hawthorn on th cardiovascular system / Family Practice. – 1999. – Oxford University Press. – Vol. 16, № 5. – P. 534–538 PDF

Chung Mi Ja, Sung Nak-Ju, Park Ch. еt al. Antioxidative and hypocholesterolemic activity of water-soluble pueratin glycosides in HepG2 cells and C57 BL/6J mice // European Journal of Pharmacology. – 2008. – Vol. 578. – Issues 2–3. – P. 159–170. https://doi.org/10.1016/j.ejphar.2007.09.036

Kim Y.S., Kim N.H., Jung D.H.et al. Genistein inhibits aldose reductase activity and high induced TGF-β2 expression in human lens epithelial cells / European Journal of Farmacology. – 2008. – Vol. 594. – Issues 1–3. – P. 18–25. https://doi.org/10.1016/j.ejphar.2008.07.033

M.-K., Park E.-K., Yoon H.-K., Kim D.-H. Antithrombotic and Antiallergic Activities of Daidzein, a Metabolite of Puerarin and Daidzin Produced by Human Intestinal Microflora / Biol. Pharm.Bull. Volume 5(10) 2002, P. 1328–1332. https://doi.org/10.1248/bpb.25.1328